Terms: = Lung cancer AND BAP1, DKFZp686N04275, 8314, ENSG00000163930, Q92560, KIAA0272, hucep-6, HUCEP-13, FLJ37180, FLJ35406 AND Prognosis
60 results:
1. bap1, Wilms' tumor 1, and calretinin in predicting survival and response to first-line chemotherapy in patients with pleural mesothelioma.
Yuce TH; Ak G; Metintas S; Dundar E; Roe OD; Panou V; Metintas M
J Cancer Res Clin Oncol; 2024 Jan; 150(2):38. PubMed ID: 38280040
[TBL] [Abstract] [Full Text] [Related]
2. Complete clinical remission of malignant peritoneal mesothelioma with systemic pemetrexed and bevacizumab in a patient with a bap1 mutation.
Lee J; Turetsky J; Nasri E; Rogers SC
BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38142057
[TBL] [Abstract] [Full Text] [Related]
3. Methylthioadenosine Phosphorylase and Breast cancer 1 Protein-Associated Protein 1 as Biomarkers for the Peritoneal Mesothelioma.
Chen Y; Du X; Gao Y; Wu H; Zhao H; Su Y
Cancer Control; 2023; 30():10732748231220805. PubMed ID: 38092371
[TBL] [Abstract] [Full Text] [Related]
4. Combined Inhibition of EZH2 and FGFR is Synergistic in bap1-deficient Malignant Mesothelioma.
Badhai J; Landman N; Pandey GK; Song JY; Hulsman D; Krijgsman O; Chandrasekaran G; Berns A; van Lohuizen M
Cancer Res Commun; 2024 Jan; 4(1):18-27. PubMed ID: 38054839
[TBL] [Abstract] [Full Text] [Related]
5. Molecular alterations and potential actionable mutations in peritoneal mesothelioma: a scoping review of high-throughput sequencing studies.
Dietz MV; van Kooten JP; Paats MS; Aerts JGVJ; Verhoef C; Madsen EVE; Dubbink HJ; von der Thüsen JH
ESMO Open; 2023 Aug; 8(4):101600. PubMed ID: 37453150
[TBL] [Abstract] [Full Text] [Related]
6. Target Therapy in Malignant Pleural Mesothelioma: Hope or Mirage?
Borea F; Franczak MA; Garcia M; Perrino M; Cordua N; Smolenski RT; Peters GJ; Dziadziuszko R; Santoro A; Zucali PA; Giovannetti E
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298116
[TBL] [Abstract] [Full Text] [Related]
7. Family Matters: Germline Testing in Thoracic cancers.
Hathaway F; Martins R; Sorscher S; Bzura A; Dudbridge F; Fennell DA
Am Soc Clin Oncol Educ Book; 2023 May; 43():e389956. PubMed ID: 37167572
[TBL] [Abstract] [Full Text] [Related]
8. Characterizing the distribution of alterations in mesothelioma and their correlation to morphology.
Chen-Yost HI; Tjota MY; Gao G; Mitchell O; Kindler H; Segal J; Husain AN; Mueller J; Schulte JJ
Am J Clin Pathol; 2023 Sep; 160(3):238-246. PubMed ID: 37141416
[TBL] [Abstract] [Full Text] [Related]
9. The cytological features of effusions with mesothelioma in situ: A report of 9 cases.
Michael CW; Bedrossian CCWM; Sadri N; Klebe S
Diagn Cytopathol; 2023 Jun; 51(6):374-388. PubMed ID: 36942732
[TBL] [Abstract] [Full Text] [Related]
10. A novel prognostic nomogram for predicting survival in diffuse pleural mesothelioma.
Aksoy Y; Chou A; Mahjoub M; Sheen A; Sioson L; Ahadi MS; Gill AJ; Fuchs TL
Pathology; 2023 Jun; 55(4):449-455. PubMed ID: 36842876
[TBL] [Abstract] [Full Text] [Related]
11. Mesotheliomas and Benign Mesothelial Tumors: Update on Pathologic and Imaging Findings.
Bonde A; Singh R; Prasad SR; Kamireddy D; Aggarwal A; Ramani N; Saboo S; Shanbhogue K; Dasyam AK; Katabathina VS
Radiographics; 2023 Mar; 43(3):e220128. PubMed ID: 36757881
[TBL] [Abstract] [Full Text] [Related]
12. A combination of intrinsic and extrinsic features improves prognostic prediction in malignant pleural mesothelioma.
Nguyen TT; Lee HS; Burt BM; Amos CI; Cheng C
Br J Cancer; 2022 Nov; 127(9):1691-1700. PubMed ID: 35999269
[TBL] [Abstract] [Full Text] [Related]
13. Pan-cancer analysis of the prognostic and immunological role of BRCA1-associated protein 1 gene (bap1): Friend or foe?
Wang T; Zhu T; Zhang Y; Bai J; Xue Y; Xu G; Lu L; Peng Q
Gene; 2022 Oct; 840():146765. PubMed ID: 35905855
[TBL] [Abstract] [Full Text] [Related]
14. Mesothelioma and Colorectal cancer: Report of Four Cases with Synchronous and Metachronous Presentation.
Serio G; Pezzuto F; Fortarezza F; Marzullo A; Delfino MC; d'Amati A; Romano DE; Maniglio S; Caporusso C; Lettini T; Cavone D; Vimercati L
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269773
[TBL] [Abstract] [Full Text] [Related]
15. The highlights of the 15th international conference of the international mesothelioma interest group - Do molecular concepts challenge the traditional approach to pathological mesothelioma diagnosis?
Klebe S; Galateau Salle F; Bruno R; Brcic L; I Chen-Yost H; Jaurand MC
Lung Cancer; 2022 Jan; 163():1-6. PubMed ID: 34864334
[TBL] [Abstract] [Full Text] [Related]
16. Inherited predisposition to malignant mesothelioma: germline bap1 mutations and beyond.
Pagliuca F; Zito Marino F; Morgillo F; Della Corte C; Santini M; Vicidomini G; Guggino G; De Dominicis G; Campione S; Accardo M; Cozzolino I; Franco R
Eur Rev Med Pharmacol Sci; 2021 Jun; 25(12):4236-4246. PubMed ID: 34227091
[TBL] [Abstract] [Full Text] [Related]
17. [Expression and clinical significance of SETD2 in maligant pleural mesothelioma].
Yu M; Yu M; Zhu LJ; Yuan XY; Zhang X
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2021 Feb; 39(2):91-98. PubMed ID: 33691361
[No Abstract] [Full Text] [Related]
18. TRAF7 mutations and immunohistochemical study of uterine adenomatoid tumor compared with malignant mesothelioma.
Itami H; Fujii T; Nakai T; Takeda M; Kishi Y; Taniguchi F; Terada C; Okada F; Nitta Y; Matsuoka M; Sasaki S; Sugimoto S; Uchiyama T; Morita K; Kasai T; Kawaguchi R; Ohbayashi C
Hum Pathol; 2021 May; 111():59-66. PubMed ID: 33667423
[TBL] [Abstract] [Full Text] [Related]
19. bap1 promotes viability and migration of ECA109 cells through KLF5/CyclinD1/FGF-BP1.
Wang F; Luo M; Qu H; Cheng Y
FEBS Open Bio; 2021 May; 11(5):1497-1503. PubMed ID: 33529461
[TBL] [Abstract] [Full Text] [Related]
20. Diagnostic mesothelioma biomarkers in effusion cytology.
Eccher A; Girolami I; Lucenteforte E; Troncone G; Scarpa A; Pantanowitz L
Cancer Cytopathol; 2021 Jul; 129(7):506-516. PubMed ID: 33465294
[TBL] [Abstract] [Full Text] [Related]
[Next]
